Kilpest India’s arm signs non-binding LoI to acquire 100% shares of European based company

30 Nov 2022 Evaluate

Kilpest India’s subsidiary -- 3B BlackBio Biotech India has signed a non-binding Letter of Intent (LoI) to acquire 100% shares of a European based company that specializes in the development and manufacture of innovative high-quality products for the life science and molecular diagnostic markets. The acquisition of this business would represent a strategic investment in the related field of life science research and molecular diagnostics.

The deal is subject to customary financial, legal and business due diligence, as well as regulatory approvals. An exclusivity period of 60 days has been agreed upon between the parties to complete the due diligence. The acquisition will be funded fully with internal accruals by 3B Blackbio Biotech India and its subsidiary TRUPCR Europe.

Kilpest India is one of India's leading agri-based companies. The Company manufactures, imports, exports, buys, and sells biological compounds derived from plants, animals, micro organisms.

3B Blackbio Dx Share Price

774.75 9.55 (1.25%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
UPL 455.85
BASF India 3345.50
PI Industries 3879.80
Bayer CropScience 5264.35
Sumitomo Chemical India 348.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.